E Therapeutics PLC (CE) (ETXPF) News

Form PRE 14A - Other preliminary proxy statements

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-K Filing

New York, NY, April 23, 2024 (GLOBE NEWSWIRE) -- 10X Capital Venture Acquisition Corp. III (NYSE American: VCXB) (“10X III”), announced today...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Noncompliance

New York, NY, Jan. 31, 2024 (GLOBE NEWSWIRE) -- 10X Capital Venture Acquisition Corp. III (NYSE American: VCXB, VCXB.U, VCXB WS) (“10X III”...

Form 3 - Initial statement of beneficial ownership of securities

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

10X Capital Venture Acquisition Corp. III Announces Expected Change in Management

NEW YORK, NY (United States), Jan. 08, 2024 (GLOBE NEWSWIRE) -- 10X Capital Venture Acquisition Corp. III (“10X III”) (NYSE American:VCXB), a...

Form 425 - Prospectuses and communications, business combinations

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report